Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction
GHK-Cu (skin quality) shows visible improvements in 412 weeks
Peptide Therapy at a Glance EXPECTED RESULTS Enhanced cellular repair, improved hormone balance, increased energy, better sleep, fat loss, and immune support TREATMENT LENGTH Varies daily or weekly administration over 412+ weeks depending on protocol RECOMMENDED SESSIONS Ongoing use for 13 months, with regular monitoring and dose adjustments WHERE IT TREATS Systemic works at the cellular level to support immune, endocrine, metabolic, and neurological systems WHAT IT TREATS Hormone imbalance, weight gain, poor recovery, fatigue, inflammation, aging, low libido, immune dysfunction, and neurological decline TREATMENT COST $350 $1,200/month (depending on the type of peptide and dosing protocol) What is Peptide Therapy
Radioligand and fluorescent binding assays, competition binding, recombinant receptor-expressing cell lines, functional readouts through a defined coupling pathway, and antagonist controls demonstrating that an effect is receptor-mediated
Reduce inflammation: Chronic inflammation can hinder weight loss and contribute to metabolic dysfunction
